Orange content for Mid-term 1 Flashcards
What aspect of Phase I metabolism is responsible for many drug-drug interactions?
Competition for Cytochrome P450 (CYP) enzymes.
What are common red flag drugs that are CYP enzyme inducers / inhibitors?
What is important to know about glucuronoidation in infants?
Infants are often deficient in glucuronides, so drugs may need to be given at lower doses to avoid toxicity.
What are cholinergic toxicity symptoms?
SLUDGE
MTWF
SLUDGE = muscarinic receptors
S - salivation
L - lacrimation
U - urination
D - defecation / increased motility (diarrhea)
G - GI cramping
MTWF = nicotinic receptors
M - muscles cramps
T - tachycardia
W - weakness
T - twitching
F - fasciculations (also muscle twitch)
What are the functions and common medications of adrenergic antagonists?
What is the vascular effect of minoxidil?
What is a notable SE?
What is its black box warning?
Effect: it dilates arterioles
Notable SE: hairgrowth (rogaine)
Black box warning: Pericardial effusion
- What is the effect of Sodium Nitroprusside (Nipride)?
- What is it used to treat?
- What is its route of administration?
- What are its two metabolites?
- Notable concerns?
- Notable SEs?
- Dilates both arterioles and veins
- Reduces PVR and venous return to decrease hypertension
- IV only
- NO and Cyanide are both metabolites
- long-term use can lead to cyanide poisoning.
- Delayed hypothyroidism
The major pharmacologic difference between the dihydropyridine Calcium Channel Blockers and Verapamil is
Verapamil is more cardioselective
Differences between sodium nitroprusside (nipride) and hydralazine & minoxidil include all of the following EXCEPT
- Nipride dilates both arteries and veins; hydralazine and minoxidil dilate only arterioles
- Nipride is exclusively available as an IV formulation
- Prolonged use of nipride can lead to cyanide poisoning
- Hydralazine and minoxidil have no significant adverse effects
Hydralazine and minoxidil have no significant adverse effects
What are Ace Inhibitors used to treat?
What are the concerns about ACE Inhibitors?
What is the black box warning?
What are potential effects on K? Why?
ACE-I’s are used to treat hypertension and stabilise CKD (stabilizing renal function and reducing proteinuria)
Benefits are that there is no reflex sympathetic response and no major effect on HR or CO
Negative effects of ACE inhibitors naturally follow from the blocking of Angiotensin-2 and the incresaing bradykinin.
ACE inhibitors can cause severe hypotension, in particular when combined with diuretics.
Bradykinin increase can lead to angioedema (rare but possibly fatal) and a cough (not harmful).
Black box warning: NOT FOR USE IN PREGNANCY, can cause fetal hypotension and renal damage
Orange: Risk of hyperkalemia. Careful when using with K+ supplements or potassium sparing diuretics
What are the four concerns about beta blockers?
…
With Ca channel blockers, which ones have more smooth muscle activity and which ahve more cardiac activity?
Why is this important?
….
With adrenergic blockers, what is the difference between alpha 1 and beta blockers?
….
Among the sub-classes of beta blockers, which are cardio selective and which has alpha activity?
When might one be better than the other?
….
What is the difference between vasodilators that dilate the aterioles, and those that dilate both arterioles and veins?
…
Which of the following prescriptive choices is not advisable?
- Using an alpha one antagonist in an elderly man with BPH
- Using a calcium channel blocker in a patient with angina
- Using a beta-blocker in a patient with labile type I diabetes
Using a beta-blocker in a patient with labile type I diabetes.
The reason is that it can mask symptoms of hyperglycemia.
How to ACE-I’s benefit patients with HFrEF?
Are ACE-I’s and ARBs equally effective?
- ACE-I’s affects:
- After-load reduction
- decreases amount of retained fluid volumed
- reverses cardiac remodeling
- ACE-I’s have an advantage over ARBs due to their preservation of bradykinin, which helps reduce or reverse remodeling.
What is prolematic about the inhibition of neprilysin?
What class of anti-hypertensives is a neprilysin inhibitor paired with and why?
Neprilysin breaks down ANP and BNP, so inhibiting it preserves these and helps reduce cardiac load. However, neprolysin plays a larger role than just metabolizing ANP/BNP. It also metabolizes angiotensin-II and bradykinin
Neprilysin inhibition should be paired with an ARB to suppress angiotensin-II. It should not be paired with an ACE-I, because the double-blocking of bradykinin breakdown creates a high risk of angioedema.
What is Entresto (sacubitril/valsartan)?
What is advantageous about this combination?
Sacubitril is an angiotensin receptor neprilysin inhibitor (ARNI).
Valsartan is an angiotensin receptor blocker (ARB)
The ARNI inhibits neprolysin from breaking down ANP/BNP, our natural antihypertensive. It is not paired with an ACE-I because neprolysin also breaks down bradykinin, and in this case the double blockade of bradykinin metabolism would increase the risk of angioedema. The ARB does not affect bradykinin and makes a better partner for the ARNI, which does.
What medication do you give to slow a patient’s heart rate (chronotropy) with no effect on inotropy (contractility) or other cardiac systems?
How does it work?
What is a major risk?